The Competition Commission has imposed a penalty of Rs 40 lakh on the investment manager of Goldman Sachs AIF for failing to ...

The Competition Commission of India (CCI) has fined Goldman Sachs AIF's investment manager Rs 40 lakh for not notifying a ...

Brokerages have turned bullish over Biocon's growth prospects after the US FDA clearance of the drugmaker's Malaysia unit ...

The market is expected to consolidate as long as it trades below all key moving averages. Below are some trading ideas for ...

The Competition Commission penalises Goldman Sachs AIFs investment manager Rs 40 lakh for not notifying the Biocon deal, ...

Ajit Mishra of Religare Broking suggests buying Biocon shares and Marico shares. He also suggests shorting Asian Paints ...

Zomato slips on Jefferies' downgrade, Biocon rallies on USFDA approval and Jefferies upgrade, ONGC gains as CLSA names it a ...

Biocon has experienced a significant earnings decline over the past two years, led by a lack of potential approvals for the U ...

HSBC expects an operational turnaround for Biocon, driven by major biosimilar launches and a rebound in generics sales. The ...

Raising overseas debt has become prohibitively expensive due to the depreciating rupee, he explained, adding, "several Indian ...

Motilal Oswal (MOSL) has reiterated its "Buy" rating on HCL Technologies, setting a target price of Rs 2,400, which implies a ...

The Competition Commission of India has imposed a Rs 40 lakh penalty on Goldman Sachs AIMPL for not notifying the regulator ...